Revolade, Known in the U.S. as Promacta, Tied to Severe Hepatotoxicity Risks
The use of Revolade (eltrombopag) may cause severe hepatotoxicity and potentially deadly fatal liver injury, warns Canada’s health regulator, Health Canada, according to Healthy Canadians, Government of Canada. Revolade, which is a thrombopoietin receptor agonist, is manufactured and marketed by GlaxoSmithKline under the trade name … [Read more...] about Revolade, Known in the U.S. as Promacta, Tied to Severe Hepatotoxicity Risks
FDA and Actelion Pharmaceuticals ‘Reminder’ of Hepatotoxicity
Tracleer May Cause Hepatotoxity. In a MedWatch Alert, the FDA has notified cardiopulmonary healthcare professionals of the following: “Actelion and FDA notified healthcare professionals of changes to the prescribing information based on cases of hepatotoxity reported. The notification underscored the need to continue monthly liver … [Read more...] about FDA and Actelion Pharmaceuticals ‘Reminder’ of Hepatotoxicity
